You don't have to listen to me - you didn't address anything I actually said.
I can't short this company so have nothing to gain from 'downramping' it. My interest is in the science because the topic is connected to my area of research, and having looked at their data I think the science stinks. I don't enjoy watching retail shareholders being taken advantage of.
I'm happy to take a break from commenting on this company if you're this opposed to anyone who disagrees with you - will check back in a year's time and see how it's gone.
Ann: PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size, page-165
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $27.32K | 4.098M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 4353235 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 643561 | 4 |
View Market Depth
| Last trade - 15.51pm 26/06/2024 (20 minute delay) ? |
| PAB (ASX) Chart |